Patientensicherheit durch Qualitätssicherung in der In-vitro-Diagnostik – Webinar 2024 der Ad-hoc-Kommission In-vitro-Diagnostik der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)
The reliability of laboratory tests is ensured in particular by the interaction of regulated market access and certification of diagnostics, scientific evidence through guidelines, the guideline of the German Medical Association on quality assurance of laboratory medical examinations mentioned in § 9 of the German Medizinproduktebetreiberverordnung, as well as standardisation and accreditation. The Webinar 2024 of the Association of Scientific Medical Societies in Germany's (AWMF) Ad-hoc Commission on In-vitro Diagnostics on 9 October 2024 highlighted this thematic network in four presentations from the perspective of the Federal Ministry of Health, the AWMF Institute for Medical Knowledge Management (IMWi), the German Accreditation Body (DAkkS) and the German Medical Association.
Authors
- Albrecht Stenzinger (ORCID: https://orcid.org/0000-0003-1001-103X)
- Michael Vogeser (ORCID: https://orcid.org/0000-0002-2745-2475)
- Monika Brüggemann (ORCID: https://orcid.org/0000-0001-5514-5010)
- Henning Schliephake (ORCID: https://orcid.org/0000-0002-2008-7188)
- Ulrich Sack
Institutions
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- LMU Klinikum (DE)
- University Hospital Schleswig-Holstein (DE)
- University Hospital Leipzig (DE)
- Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie (DE)
- Berlin Heart (Germany) (DE)
- Ludwig-Maximilians-Universität München (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- PubMed
- Published
- 2025-07-11
- DOI
- https://doi.org/10.3205/000341
- Primary Topic
- Medical and Health Sciences Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00